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Histone modifications play a complex role in the regulation of transcription. Recent studies (Duncan 
et al., 2008; Lee et al., 2007; Li et al., 2008) reveal that regulation of histone modifications can be 
functionally linked to reinforce the activation or repression of gene expression.Chromosomal processes such as transcription are influenced 
by a variety of posttranslational modifications to histones, 
including acetylation, phosphorylation, methylation, and ubi­
quitination. These modifications may act alone or in concert in 
a context­dependent manner to facilitate or repress chroma­
tin­mediated processes (Berger, 2007). Some histone modi­
fications are thought to influence nucleosome stability, but 
an exciting emerging theme is that histone modifications can 
influence one another such that one modification recruits or 
activates chromatin­modifying complexes to generate a dif­
ferent histone modification. There appear to be three main 
crossregulatory mechanisms that allow reinforcement of the 
actions of histone modifications in regulating gene expression. 
One mechanism is mediated by an initial histone modification 
that triggers increased activity in a histone­modifying enzyme. 
A second mechanism involves the coordination of different his­
tone­modifying enzymes present in the same protein complex. 
The third mechanism connects histone modifications to the 
cleavage of the N­terminal tail of histone H3, providing a new 
way for a histone modification­activated enzymatic activity to 
achieve an irreversible modification.
Histone Modification Crosstalk
The earliest examples of histone modification crosstalk—one 
histone modification promoting the generation of another—
were observed for modifications on the same histone tail. In the 
budding yeast Saccharomyces cerevisiae, phosphorylation of 
serine 10 (S10) on histone H3 by the Snf1 kinase promotes the 
acetylation of H3 lysine 14 (K14) by the Gcn5 acetyltransferase, 
enhancing H3’s interaction with the 14­3­3 proteins Bmh1 and 
Bmh2 during gene activation (Walter et al., 2008). Acetylation of 
mammalian H3 on lysine 18 (K18) and lysine 23 (K23) promotes 
the methylation of arginine 17 (R17) by the CARM1 methyl­
transferase, resulting in activation of estrogen­ responsive 
genes (Daujat et al., 2002). Histone modification crosstalk can 
also direct the loss of particular modifications. For example, 
in budding yeast, the RNA polymerase II­associated Set2 
methyl transferase methylates H3 lysine 36 (K36), creating a 
mark that targets nucleosomes for H3 and H4 deacetylation 
by the Rpd3S deacetylase complex after the passage of RNA 
polymerase (Lee and Shilatifard, 2007).
Some of the most interesting examples of histone modification 
crosstalk involve trans­histone effects, where one histone and 
its modifications affect the modification of a different histone. Of 
particular interest is the role of H2B monoubiquitination, a modi­604 Cell 135, November 14, 2008 ©2008 Elsevier Inc.fication that modulates multiple methylation events on histone 
H3 in S. cerevisiae. H2B ubiquitination by the Rad6 enzyme is 
necessary to trigger H3 lysine 4 (H3K4) methylation by the Set1 
methyltransferase subunit of the COMPASS complex and H3 
lysine 79 (H3K79) methylation by the Dot1 methyltransferase 
(Weake and Workman, 2008). Lee et al. (2007) provide insight into 
the mechanism governing this crosstalk. The COMPASS meth­
yltransferase complex requires the Cps35 subunit to methylate 
H3K4. However, Cps35 will only associate with COMPASS when 
it is bound to chromatin containing ubiquitinated H2B (UbH2B). 
Lee and colleagues find that Cps35 binds to chromatin containing 
UbH2B before associating with the COMPASS complex and acti­
vating it for H3K4 methylation. Methylation of H3K79 by the Dot1 
methyltransferase also requires ubiquitination of H2B (Weake and 
Workman, 2008). In the budding yeast, H3K79 methylation is also 
dependent on Cps35, suggesting a crosstalk mechanism simi­
lar to that observed with COMPASS (Lee et al., 2007). However, 
recent in vitro experiments show that chemically ubiquitinated 
H2B, when incorporated into nucleosomes, could directly stimu­
late the catalytic activity of recombinant human Dot1, suggesting 
an additional mechanism for direct UbH2B and H3K79 interaction 
and crosstalk (McGinty et al., 2008).
Deubiquitination of H2B also affects H3 methylation. H2B is 
deubiquitinated by the Ubp8 ubiquitin protease, a component 
of the SAGA acetyltransferase complex in budding yeast, flies, 
and mammals (Weake and Workman, 2008). In budding yeast, 
deubiquitination of H2B by Ubp8 allows Ctk1 kinase to associ­
ate with nucleosomes at the 5′ end of genes. This permits Ctk1 
to phosphorylate serine 2 on the RNA polymerase II C­terminal 
repeats. The Set2 methyltransferase then associates with ser­
ine 2 phosphorylated RNA polymerase II and travels with the 
polymerase to methylate H3 at lysine 36 in the open reading 
frames of genes (Wyce et al., 2007). Thus, H2B ubiquitination 
and deubiquitination act as master switches, regulating mul­
tiple methylation events on histone H3. Histone modifications, 
and even modification of RNA polymerase II, are involved in 
crosstalk at many steps during transcription and may serve 
as checkpoints for the correct assembly of the machinery 
required to accurately load and launch RNA polymerase during 
gene expression.
Multifunctional Histone Modification Complexes
An increasing number of chromatin­modifying complexes are 
found to contain more than one distinct histone­modifying 
enzyme. These enzymes may act independently, but, in some 
cases, they work together to coordinate histone modifications. 
For example, the mammalian MLL3/4 Set1­H3K4 methyl­
transferase complex coordinates the removal of a repressive 
methyl mark with the formation of an activating methyl mark on 
histone H3. This protein complex contains H3K4 methylation 
activity (an activating mark), as well as a subunit called UTX 
that removes the transcriptionally repressive methyl mark from 
H3K27 (Figure 1A) (Cho et al., 2007).
Other examples of two histone­modifying enzymes in the 
same macromolecular protein complex can be found in the 
Polycomb group (PcG) of transcriptional silencing complexes. 
The PcG silencing complexes consist of three separate protein 
complexes (PRC1, PRC2, and PhoRC) that assemble on chro­
matin and coordinate H2A lysine 119 (H2AK119) ubiquitination 
and H3K27 methylation (Schwartz and Pirrotta, 2007). Poly­
comb repressive complex 1 (PRC1) was initially purified from 
the fruit fly Drosophila melanogaster and contains the proteins 
Polycomb (PC), Posterior sex combs (PSC), polyhomeotic (PH), 
dRING, and Sex comb on midleg (SCM) (Figure 1). The mam­
malian PRC1 complex purified from cultured HeLa cells is simi­
lar to that of Drosophila. The dRING subunit of PRC1 and its 
mammalian homologs, RING1A and B, function as E3 ubiquitin 
ligases and monoubiquitinate H2AK119. Polycomb repressive 
complex 2 (PRC2), or the E(Z)/ESC complex, contains the E(Z) 
H3K27 methyltransferase. The PhoRC complex, identified in 
Drosophila, contains the pleiohomeotic/pleiohomeotic­like 
(PHO/PHOL) proteins (homologs of mammalian Yin­Yang1) and 
binds to DNA (Schwartz and Pirrotta, 2007). The recruitment of 
PcG silencing components in Drosophila is hierarchical (Martin 
and Zhang, 2005): PHO and PHOL are first bound to a Poly­
comb­specific site (PRE) in the DNA. The E(Z) complex is then 
recruited to this PRE site through interactions with PHO and 
Figure 1. Crossregulation among Histone 
Modifications
(A) Shown is a complex containing demethylase 
and methyltransferase enzymes that coordinates 
the removal of a repressive mark—methylation of 
histone H3 on lysine 27 (H3K27)—with the forma­
tion of an activating mark—methylation of histone 
H3 on lysine 4 (H3K4). The MLL3/4 Set1­H3K4 
methyltransferase complex is recruited by WD40 
domain proteins (WDR2 and RBBP2) that recog­
nize H3K4 at active regions of the Hox genes. The 
UTX subunit of the complex demethylates di­ and 
trimethylated H3K27.
(B) Crossregulation of histone H3 lysine 27 (H3K27) 
methylation, histone H3 lysine 36 (H3K36) demeth­
ylation, and H2A ubiquitination during transcrip­
tional silencing. The Drosophila dRAF (dRING­
associated factors) complex contains RING, PSC, 
Ulp1, MOR, and the KDM2 H3K36 demethylase. 
dRAF demethylates H3K36, an activating mark, 
and ubiquitinates H2A lysine 119 (H2AK119), a 
repressive mark, through the actions of dRING/
PSC proteins in cooperation with the PcG com­
plex. Association of PcG complexes results in the 
methylation of histone H3 on lysine 27 (H3K27), 
a repressive mark, by the E(Z) methyltransferase. 
dRAF is a separate PcG complex that cooperates 
with PRC1 in transcriptional silencing.
(C) Lid2, a histone H3 lysine 4 (H3K4) demethy­
lase, coordinates H3K4 demethylation and H3K9 
methylation with the RNA interference pathway. In 
the fission yeast S. pombe, H3K9 methylation in 
heterochromatin is catalyzed by Clr4 in associa­
tion with Rik. H3K9 methylation is linked to small 
interfering RNA (siRNA) production by Clr4­ and 
Clr8­mediated association with the RITS (RNA­
induced initiation of transcriptional gene silencing) 
complex. H3K9 methylation also creates the bind­
ing site for Swi6, resulting in transcriptional repres­
sion. Lid2 is recruited to the Clr4­Clr7­Clr8 com­
plex through an interaction with Clr8. The H3K4 
demethylase activity of Lid2 is required for H3K9 
methylation by the complex and is also needed for 
the production of small RNAs and the loading of 
RITS onto heterochromatin.
(D) Histone modifications and H3 cleavage. The 
N­terminal tail of the histone H3.2 is cleaved be­
tween amino acids 21 and 22 by cathepsin L dur­
ing differentiation of mouse embryonic stem cells. 
This cleavage is enhanced by methylation of his­
tone H3 lysine 27 (H3K27). Binding of the mouse 
CBX7 Polycomb protein to methylated H3K27 is 
disrupted by cathespin L cleavage of H3.Cell 135, November 14, 2008 ©2008 Elsevier Inc. 605
PHOL. The E(Z) complex methylates H3K27, forming a binding 
site for PC, the protein required to recruit PRC1. Once bound 
to the PRE, PRC1 mediates ubiquitination of H2AK119, pos­
sibly indirectly through the dRAF complex (Figure 1B). Thus, 
the Polycomb group complexes coordinate and establish two 
repressive marks on chromatin.
A recent study shows that in Drosophila, the PRC1 subunits 
dRING and PSC also form another Polycomb complex called 
dRAF (dRING­associated factors), which is distinct from PRC1 
(Lagarou et al., 2008). Interestingly, dRAF contains the dKDM2 
protein that removes dimethyl groups from K36 (Figure 1B). 
dKDM2 enhances homeotic gene silencing by PcG complexes, 
suggesting that the dRAF and PRC1 complexes cooperate in 
vivo. dKDM2 also stimulates H2A ubiquitination by dRING/
PSC in a manner independent of dKDM2 catalytic activity 
(Lagarou et al., 2008). Thus, the dRAF complex can coordinate 
the removal of an active mark, H3K36me2, with addition of a 
repressive mark, H2AK119 ubiquitination, although neither of 
these two activities appears to depend on the other (Figure 
1B).
A recent study in Cell by Li et al. (2008) provides another 
example of histone modification coordination by a protein 
complex in the fission yeast Schizosaccharomyces pombe, 
but in this case, the modification activities may be interdepen­
dent. Heterochromatin in S. pombe is found at centromeres, 
telomeres, and the mating­type region. These heterochro­
matic regions are enriched in H3K9 methylation catalyzed 
by Clr4, the homolog of the mammalian histone methyltrans­
ferase SUV39H1. The catalytic activity of Clr4 is dependent 
on its association with Rik1, a WD40­repeat protein that is the 
homolog of the human DNA damage binding protein (DDB1). 
These two proteins form a complex with Clr7 and Clr8 chro­
matin binding factors and the Cul4 ubiquitin ligase to promote 
H3K9 methylation by Clr4. Li et al. demonstrated that the JmjC 
domain protein Lid2, a H3K4­specific demethylase, binds to 
this protein complex through an interaction with Clr8. Lid2 pro­
motes heterochromatin formation by removing the activating 
H3K4 methyl marks. Surprisingly, the H3K4 methylation activity 
of Lid2 in the Clr4/7/8­Rik­Cul4 complex facilitates the H3K9 
methylation activity of this complex, thereby functionally link­
ing H3K9 methylation with H3K4 demethylation in the forma­
tion of heterochromatin (Figure 1C). Li and colleagues report 
that Lid2 may also play a role in euchromatin, coordinating the 
Set1 methyltransferase and the Lsd1 demethylase to regulate 
H3K4 and H3K9 methylation levels, although this function is 
less clear and may not depend on Lid2 enzymatic activity.
Histone methylation and demethylation are also intimately 
connected with the RNA interference (RNAi) pathway of gene 
silencing. In S. pombe, deletion of Clr4 (the H3K9 methyltrans­
ferase) abolishes the generation of small interfering RNAs (siR­
NAs), revealing a self­enforcing loop and interdependence of 
histone methylation and the RNAi pathway (Buhler et al., 2006). 
The binding of the RNA­induced initiation of transcriptional 
gene silencing (RITS) complex to centromeres requires H3K9 
methylation and the presence of the chromatin factors Swi6 
and HP1 (Buhler et al., 2006). Li et al. (2008) now show a further 
link by demonstrating that demethylation of H3K4 by Lid2 is 
also required for the loading of RITS onto centromeres (Fig­606 Cell 135, November 14, 2008 ©2008 Elsevier Inc.ure 1C). A similar connection between methylation and RNA 
is observed in the ciliated protozoan Tetrahymena. Although 
H3K27 methylation is not directly coupled with generation 
of siRNAs, generation of methyl marks by the enzyme EZL1 
requires the RNAi pathway (Liu et al., 2007). RNAi­dependent 
H3K27 methylation is in turn required for heterochromatin for­
mation and for H3K9 methylation.
The RNAi pathway has also been linked to histone methy­
lation and transcriptional gene silencing in Drosophila and 
mammals. For example, components of the RNAi machinery 
are involved in PcG­mediated transcriptional repression at the 
PREs of the Fab­7 regulatory element in Drosophila. In mam­
mals, microRNAs and RNAi pathway components also have 
been shown to participate in the repression of target promot­
ers, the recruitment of PcG components, and the methylation 
of H3K27 (e.g., Kim et al., 2008). Clearly, the RNAi pathway 
plays important roles in mediating transcriptional gene silenc­
ing in cooperation with multifunctional histone modification 
enzymes such as PcG complexes.
Cleaving Histones and Their Modifications
A recent study by Duncan et al. (2008) in Cell suggests that 
histone modifications may also be linked to cleavage of the his­
tone H3 tail. This would represent a radically different approach 
to irreversibly undoing a set of previous histone modifications. 
The unstructured N­terminal tails of the core histones are 
extremely sensitive to proteolysis compared to more struc­
tured regions of histone proteins. In spite of their inherent 
protease sensitivity, surprisingly few examples of in vivo pro­
teolysis of histone tails have been reported. These biological 
examples of histone tail proteolysis also tend to occur under 
very specialized circumstances. For example, in Tetrahymena, 
six amino acids are proteolytically cleaved from the N­termi­
nal tail of H3 in the chromatin of the germline micronucleus 
with unknown functional consequences (Allis et al., 1980). In 
cultured mammalian cells infected with the virus causing foot­
and­mouth disease (FMDV), normal H3 is replaced by a protein 
called Pi that is generated by proteolytic cleavage of H3 by the 
viral FMDV 3C protease (Falk et al., 1990). Viral 3C protease­
mediated removal of the 20 N­terminal amino acids of H3 may 
be a mechanism for shutting off host cell transcription (Falk et 
al., 1990).
These specialized examples suggest that histone tail cleav­
age may not play a major role in chromatin regulation. How­
ever, Duncan et al. (2008) now uncover proteolytic cleavage of 
histone H3 in mammalian cells, an event that may be important 
for early stem cell differentiation. In histone preparations from 
differentiating murine embryonic stem cells (ESCs), Duncan 
and colleagues observed the appearance of a shorter form of 
histone H3 lacking the N terminus. This truncated H3 associ­
ates with chromatin and appears when expression of the cru­
cial stem cell renewal factor Oct3/4 is lost. Mass spectrometry 
analysis and sequencing reveal that the truncated form of H3 
is derived from the H3.2 variant of histone H3 and is cleaved at 
several sites between amino acids 21 and 28, with the primary 
cleavage site between amino acids 21 and 22. Mass spectrom­
etry analysis of a partially purified H3 cleavage activity from 
differentiating ESCs reveals that cathepsin L, a member of the 
papain family of lysosomal proteases, is the protease respon­
sible for the histone cleavage. Although most members of the 
papain family reside in lysosomes, a nuclear form of cathepsin 
L has been identified as a regulator of cell cycle progression 
through proteolytic processing of the CDP/Cux transcription 
factor (Goulet et al., 2004). Indeed, Duncan and coworkers 
observe association of cathepsin L with chromatin upon the 
differentiation of ESCs.
Interestingly, Duncan et al. find that the truncated H3 and 
the peptides cleaved from its N terminus contain both activat­
ing and repressive modification marks. As recombinant cathe­
psin L had similar H3 cleavage activity to the native protein, 
the authors used it to test whether histone modifications affect 
cleavage by cathepsin L. Duncan et al. show that methylation 
of H3 on K27 increases H3 cleavage. Intriguingly, acetylation 
of lysine 18 (K18) increases cleavage, whereas K23 acetyla­
tion reduces it, indicating that the location of the acetylation 
has distinct effects on cathepsin L activity. Cathepsin L cleav­
age reduces the binding nearby of the mouse Polycomb pro­
tein (CBX7) to H3 methylated at K27. This suggests that H3 
tail cleavage could serve to release Polycomb proteins from 
K27 methylated H3, thereby derepressing genes in differenti­
ating ESCs (Figure 1D). Thus, adjacent histone modifications 
may regulate the cleavage of histone H3 by cathepsin L and be 
regulated in turn by cathepsin L cleavage through the removal 
of modifications marking the H3 N terminus. It is not yet clear 
what role cathepsin L cleavage of H3 plays in the differentiation 
of ESCs. However, a potential role for cathepsin L in the epige­
netic regulation of gene expression is supported by the abnor­
mal distribution of heterochromatic and euchromatic marks 
and factors in cultured cells lacking cathepsin L (Bulynko et 
al., 2006). Thus, it is possible that cathepsin L and the histone 
modifications that control its activity play an important role in 
regulating the distribution of heterochromatic and euchromatic 
marks across the genome in ways yet to be determined.
The recent progress in understanding crossregulation among 
histone modifications suggests that there is much more to learn. 
There are undoubtedly more modifications and mechanisms of 
recognition to be discovered. Initial paradigms of known modi­
fications are also being challenged by discoveries of new func­
tions for histone modifications in different contexts. There is also 
the possibility that new combinations of histone modifications will 
have functions that are distinct from those of the individual modi­
fications alone. Indeed, the histone code seems like a complex 
language in which we are still studying individual letters (Berger, 
2007). This lack of knowledge remains the true limitation in mak­
ing use of the results of epigenomic projects that map global his­
tone modifications in multiple cell types and organisms.ACknowledgMents
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